Mexiletine, a decades-old drug previously used to treat abnormal heart rhythms, has been used to alleviate the symptoms of patients with nondystrophic myotonias (NDMs), rare diseases that affect the skeletal muscle and cause functionally limiting stiffness and pain.
The preliminary research, published today in The Journal of the American Medical Association, shows that taking mexiletine can improve patient-reported stiffness.